1[1]UK Prospective Diabetes Study Group: Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type
2[2]diabetes(UKPDS 33). Lancet 1998, 352: 837～ 853.2.Amerian Diabetes Association: Implication of United Kingdom Prospective Diabetes Study. Diabetes Care 2000, 23 (Suppl1) :S27～S31.
3[3]Bloomgarden ZT. American Diabetes Assocation 60yh Scienftific Session, 2000: Cardiovascular disease in diabetes, Diabetes Care 2001;24:399～404.
4[4]American Diabetes Association:Translation of the Diabetes Nutrition Recommendations for Health Care Institutions. Diabetes Care 2001,24(suppl 1):S48～S50.
5[5]American Diabetes Association: Nutrition Recommendations and Principles for People with DIabetes Mellitus. Diabetes Care 2001,24(suppl 1):S44～S47.
6[6]Dreon DM, Uranizan KM, Krauss RM, et al. The effects of polyunsaturated fat vs monounsaturated fat on plasma lipoproteins. JAMA 1990 ;263:2462～ 2466.
7[7]Harris WS. n - 2 fatty acids and serum lipoproteins: Human studies. Am J Clin Nutr 1997, 65(suppl): 1645S～ 1649S.
8[8]Pickup J, Williams G. Toxtbook of Diabetes. In: Nilsson PM. Hypertension and diabetes mellitus. eds. Blackwell of Science Ltd 1997:56～ 61.
9Acquadro C, Jambon B, Ellis D, et al. Language and translation issues. In: Spilker B,ed. 2nd. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott, 1996.575-585.
10Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.Lancet,2003,361:449-456.
